Cristina DE MIN,Walter FERLIN,Fabrizio DE BENEDETTI
申请号：
US16831351
公开号：
US20200291110A1
申请日:
2020.03.26
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The disclosure relates generally to methods compositions and dosing regimens for treating, preventing and/or delaying the onset or progression of, or alleviating a symptom associated with elevated IFN-γ levels.
